Proto Script Pharmaceutical
(OTC) PSCR
Proto Script Pharmaceutical Financials at a Glance
Market Cap
$5,700
Revenue (TTM)
$604.98K
Net Income (TTM)
$8.39M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
27.92 (High)
Dividend
$0.00
Beta (Volatility)
27.92 (High)
Price
$0.00
Volume
1,900
Open
$0.00
Price
$0.00
Volume
1,900
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
27.92 (High)
Price
$0.00
Volume
1,900
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
PSCR News
PSCR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Proto Script Pharmaceutical
Industry
Healthcare Providers and Services
Sector
Health CareHeadquarters
Rancho Cucamonga, CA 91730, US
PSCR Financials
Key Financial Metrics (TTM)
Gross Margin
72%
Operating Margin
-38%
Net Income Margin
-9%
Return on Equity
0%
Return on Capital
93%
Return on Assets
-42%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
-0.83%
Stock Overview
Market Cap
$5.70K
Shares Outstanding
56.90M
Volume
1.90K
Short Interest
0.00%
Avg. Volume
145.902
Financials (TTM)
Gross Profit
$564.47K
Operating Income
$298.08K
EBITDA
$292.96K
Operating Cash Flow
$44.10K
Capital Expenditure
$15.23K
Free Cash Flow
$28.88K
Cash & ST Invst.
$3.51K
Total Debt
$51.29K
Proto Script Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$251.97K
+17.8%
Gross Profit
$213.78K
+22.6%
Gross Margin
84.84%
N/A
Market Cap
$5.70K
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$283.65K
-190471.1%
EBITDA
$163.56K
-11892.0%
Quarterly Fundamentals
Net Cash
$372.75K
-387.6%
Accounts Receivable
$166.44K
-32.7%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$372.75K
+353.3%
Return on Assets
-42.20%
N/A
Return on Invested Capital
93.23%
N/A
Free Cash Flow
$24.90K
+39.6%
Operating Cash Flow
$24.30K
+36.4%